213 related articles for article (PubMed ID: 35240934)
1. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
[TBL] [Abstract][Full Text] [Related]
3. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
Hoque SA; Kobayashi M; Takanashi S; Anwar KS; Watanabe T; Khamrin P; Okitsu S; Hayakawa S; Ushijima H
Vaccine; 2018 Jan; 36(1):43-49. PubMed ID: 29183732
[TBL] [Abstract][Full Text] [Related]
4. Rotavirus genotype and Vesikari score of outpatients in Japan in the vaccine era.
Ono M; Tsugawa T; Nakata S; Kondo K; Tatsumi M; Tsutsumi H; Kawasaki Y
Pediatr Int; 2020 May; 62(5):569-575. PubMed ID: 31957129
[TBL] [Abstract][Full Text] [Related]
5. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
Payne DC; Selvarangan R; Azimi PH; Boom JA; Englund JA; Staat MA; Halasa NB; Weinberg GA; Szilagyi PG; Chappell J; McNeal M; Klein EJ; Sahni LC; Johnston SH; Harrison CJ; Baker CJ; Bernstein DI; Moffatt ME; Tate JE; Mijatovic-Rustempasic S; Esona MD; Wikswo ME; Curns AT; Sulemana I; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2015 Dec; 61(12):1792-9. PubMed ID: 26449565
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
[TBL] [Abstract][Full Text] [Related]
7. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccination in Japan: Efficacy and safety of vaccines, changes in genotype, and surveillance efforts.
Tsugawa T; Akane Y; Honjo S; Kondo K; Kawasaki Y
J Infect Chemother; 2021 Jul; 27(7):940-948. PubMed ID: 33867267
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
Banajeh SM; Abu-Asba BA
BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
[TBL] [Abstract][Full Text] [Related]
10. G1P[8] species A rotavirus over 27 years--pre- and post-vaccination eras--in Brazil: full genomic constellation analysis and no evidence for selection pressure by Rotarix® vaccine.
da Silva MFM; Rose TL; Gómez MM; Carvalho-Costa FA; Fialho AM; de Assis RMS; de Andrade JDSR; Volotão EM; Leite JPG
Infect Genet Evol; 2015 Mar; 30():206-218. PubMed ID: 25562122
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
13. Monovalent Rotavirus Vaccine Efficacy Against Different Rotavirus Genotypes: A Pooled Analysis of Phase II and III Trial Data.
Amin AB; Tate JE; Waller LA; Lash TL; Lopman BA
Clin Infect Dis; 2023 Feb; 76(3):e1150-e1156. PubMed ID: 36031386
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.
Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J
Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903
[TBL] [Abstract][Full Text] [Related]
15. Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
Markkula J; Hemming-Harlo M; Vesikari T
Vaccine; 2020 Feb; 38(6):1378-1383. PubMed ID: 31862199
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.
Guerra SF; Linhares AC; Mascarenhas JD; Oliveira A; Justino MC; Soares LS; Müller EC; Brasil P; Tuboi S; Ortega-Barria E; Colindres R
J Med Virol; 2015 Aug; 87(8):1303-10. PubMed ID: 25879653
[TBL] [Abstract][Full Text] [Related]
17. Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines.
Chung JY; Kim MS; Jung TW; Kim SJ; Kang JH; Han SB; Kim SY; Rhim JW; Kim HM; Park JH; Jo DS; Ma SH; Jeong HS; Cheon DS; Kim JH
J Korean Med Sci; 2015 Oct; 30(10):1471-5. PubMed ID: 26425045
[TBL] [Abstract][Full Text] [Related]
18. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016.
Payne DC; Englund JA; Weinberg GA; Halasa NB; Boom JA; Staat MA; Selvarangan R; Azimi PH; Klein EJ; Szilagyi PG; Chappell J; Sahni LC; McNeal M; Harrison CJ; Moffatt ME; Johnston SH; Mijatovic-Rustempasic S; Esona MD; Tate JE; Curns AT; Wikswo ME; Sulemana I; Bowen MD; Parashar UD
JAMA Netw Open; 2019 Sep; 2(9):e1912242. PubMed ID: 31560386
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
Ali Z; Harastani H; Hammadi M; Reslan L; Ghanem S; Hajar F; Sabra A; Haidar A; Inati A; Rajab M; Fakhouri H; Ghanem B; Baasiri G; Gerbaka B; Zaraket H; Matar GM; Dbaibo G
PLoS One; 2016; 11(8):e0161345. PubMed ID: 27571515
[TBL] [Abstract][Full Text] [Related]
20. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
